查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1654370

美国週边血管血管造影术剂市场规模、份额、趋势分析报告：按方式、产品、最终用途和细分市场预测，2025 年至 2030 年

U.S. Peripheral Vascular Angiography Contrast Media Market Size, Share & Trends Analysis Report By Modality (Ultrasound, Magnetic Resonance Imaging, CT/X-ray), By Product, By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

美国週边血管造影术剂市场的成长与趋势

根据Grand View Research, Inc.的最新报告，美国週边血管造影术剂市场规模预计到2030年将达到3.3181亿美元，2025年至2030年期间的复合年增长率为6.29%。血管疾病的发生率日益上升，尤其是在老龄化社会以及患有糖尿病、高血压和肥胖症等文明病的患者中，推动了对先进诊断成像的需求。週边血管造影术利用显影剂增强血管的可见度，对于早期发现和准确诊断周边动脉疾病和其他循环系统疾病至关重要。

糖尿病、肥胖症、高血压和吸烟等与文明病在世界各地变得越来越普遍。这些情况显着增加了罹患週边血管疾病的风险。例如，糖尿病和高血压会损害血管并增加血管併发症的可能性。随着全球范围内患有这些文明病的患者数量不断增加，对诊断影像的需求也相应增加。週边血管造影术利用显影剂提供清晰、详细的血管影像，对于诊断这些疾病并及时进行医疗干预至关重要。文明病盛行率的增加直接推动了对血管造影术剂的需求。据叶迪特佩大学医院称，到 2025 年，高血压患者数量预计将达到 15 亿。 60 岁以上的人中，有三分之一患有高血压。

然而，限制市场成长的主要因素之一是诊断影像（尤其是血管造影术）的成本高昂。先进的影像技术，例如用于週边血管造影术的技术，需要昂贵的设备、熟练的工作人员和特殊的显影剂。高昂的费用可能会限制人们获得这些手术的机会，特别是在医疗预算较低的地区，并会使一些患者和医疗服务提供者不愿意选择诊断性血管造影术。此外，保险不足的患者可能面临自付费用，从而减少对这些服务的整体需求。

美国血管造影术造影剂市场报告重点

  • 根据产品，CT/X射线领域预计将在 2024 年占据市场主导地位，并在 2025 年至 2030 年期间实现显着的复合年增长率。先天性心臟疾病（CHD）盛行率的上升导致CT血管摄影的需求大幅增加。
  • 根据方式，市场以碘基显影剂，这种造影剂在X光、CT和血管造影术等显像模式中可以非常有效地提高血管的可见度。
  • 根据最终用途，医院部门预计将在 2024 年占据市场主导地位，并在预测期内实现显着成长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章美国週边血管血管造影术剂市场变数、趋势与范围

  • 市场体系展望
    • 补贴市场前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
    • 市场机会分析
    • 市场问题分析
  • 美国週边血管血管造影术显影剂市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章美国週边血管造影术造影剂市场：按产品分類的估计和趋势分析

  • 细分仪表板
  • 美国血管血管造影术剂市场波动分析
  • 美国週边血管血管造影术显影剂市场规模及趋势分析（依产品划分），2018 年至 2030 年
  • CT/X光
  • 磁振造影
  • 超音波

第五章美国週边血管血管造影术剂市场按方式、估计和趋势分析

  • 细分仪表板
  • 美国血管血管造影术剂市场波动分析
  • 2018 年至 2030 年美国週边血管血管造影术剂市场规模及趋势分析（依治疗方式）
  • 碘显影剂
  • 钆显影剂
  • 微气泡

第六章美国外周血血管造影术造影剂市场：按最终用途分類的估计和趋势分析

  • 细分仪表板
  • 美国血管血管造影术剂市场波动分析
  • 2018 年至 2030 年美国週边血管血管造影术剂市场规模及趋势分析（依最终用途）
  • 医院
  • 诊断影像中心
  • 研究所
  • 其他的

第七章 竞争格局

  • 公司/竞争对手分类
  • 战略地图
  • 2024 年企业市场分析
  • 主要认证提供者/计画所有者列表
  • 公司简介/上市公司
    • Lantheus Holdings, Inc.
    • Guerbet
    • Bracco
    • Bayer
    • GE HealthCare
    • Fresenius Kabi USA
Product Code: GVR-4-68040-506-5

U.S. Peripheral Vascular Angiography Contrast Media Market Growth & Trends:

The U.S. peripheral vascular angiography contrast media market size is anticipated to reach USD 331.81 million by 2030 expanding at a CAGR of 6.29% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of vascular diseases, particularly among the aging population and individuals with lifestyle-associated conditions such as diabetes, hypertension, and obesity, is driving demand for advanced diagnostic imaging. Peripheral vascular angiography procedures, which utilize contrast agents to enhance the visibility of blood vessels, are essential for the early detection and accurate diagnosis of peripheral artery disease and other circulatory disorders.

Lifestyle-associated diseases, such as diabetes, obesity, hypertension, and smoking, are becoming more common worldwide. These conditions significantly increase the risk of developing peripheral vascular diseases. For instance, diabetes and hypertension can damage blood vessels, leading to a higher likelihood of vascular complications. As the number of individuals living with these lifestyle-related conditions continues to grow globally, there is an associated rise in the demand for diagnostic imaging. Peripheral vascular angiography, which utilizes contrast media to provide clear and detailed images of the blood vessels, is crucial in diagnosing these conditions and enabling timely medical interventions. This increasing prevalence of lifestyle-related disorders directly drives the demand for angiography contrast media. According to Yeditepe University Hospital, by 2025, hypertension patients are expected to reach 1.5 billion. 1 in 3 people over the age of 60 have hypertension.

However, one of the major factors restraining the growth of the market is the high cost of diagnostic imaging procedures, particularly angiography. Advanced imaging technologies, such as those used in peripheral vascular angiography, require expensive equipment, skilled personnel, and specialized contrast media. This high cost can limit access to these procedures, particularly in regions with lower healthcare budgets, and may deter some patients or healthcare providers from opting for diagnostic angiography. Moreover, patients without adequate insurance coverage may face out-of-pocket costs, reducing the overall demand for these services.

U.S. Peripheral Vascular Angiography Contrast Media Market Report Highlights:

  • Based on the product, The CT/X-ray segment dominated the market in 2024 and is expected to register a significant CAGR from 2025 to 2030. The rising prevalence of congenital heart diseases (CHDs) significantly increases the demand for CT angiography.
  • Based on the modality, Iodinated contrast media dominate the market due to their high efficacy in enhancing the visibility of blood vessels in imaging modalities such as X-ray, CT, and angiography.
  • Based on end use, the hospital segment dominated the market in 2024, and it is expected to witness significant growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Peripheral Vascular Angiography Contrast Media Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing burden of peripheral artery disease
      • 3.2.1.2. Rising demand for medical imaging
      • 3.2.1.3. Increasing prevalence of aging population
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost associated with angiography procedures
      • 3.2.2.2. Complications associated with the use of contrast agent during procedures
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Rising number of clinical trials
      • 3.2.3.2. Growing prevalence of lifestyle associated disorders
      • 3.2.3.3. Increasing regulatory approvals and launches among developed countries
    • 3.2.4. Market Challenge Analysis
  • 3.3. U.S. Peripheral Vascular Angiography Contrast Media Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining Power Of Suppliers
      • 3.3.1.2. Bargaining Power Of Buyers
      • 3.3.1.3. Threat Of Substitutes
      • 3.3.1.4. Threat Of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological Landscape

Chapter 4. U.S. Peripheral Vascular Angiography Contrast Media Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 4.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. CT/X-ray
    • 4.4.1. CT/X-ray U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Magnetic Resonance Imaging
    • 4.5.1. Magnetic Resonance Imaging U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Ultrasound
    • 4.6.1. Ultrasound U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. U.S. Peripheral Vascular Angiography Contrast Media Market: Modality Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 5.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 5.4. Iodinated Contrast Media
    • 5.4.1. Iodinated Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Gadolinium-based Contrast Media
    • 5.5.1. Gadolinium-based Contrast Media U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Microbubble
    • 5.6.1. Microbubble U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. U.S. Peripheral Vascular Angiography Contrast Media Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Peripheral Vascular Angiography Contrast Media Market Movement Analysis
  • 6.3. U.S. Peripheral Vascular Angiography Contrast Media Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Diagnostic Imaging Centers
    • 6.5.1. Diagnostic Imaging Centers U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Research Institutes
    • 6.6.1. Research Institutes U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others U.S. Peripheral Vascular Angiography Contrast Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. List of Key Certification Providers/Scheme Owners
  • 7.5. Company Profiles/Listing
    • 7.5.1. Lantheus Holdings, Inc.
      • 7.5.1.1. Company overview
      • 7.5.1.2. Financial performance
      • 7.5.1.3. Product Type benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Guerbet
      • 7.5.2.1. Company overview
      • 7.5.2.2. Financial performance
      • 7.5.2.3. Product Type benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Bracco
      • 7.5.3.1. Company overview
      • 7.5.3.2. Financial performance
      • 7.5.3.3. Product Type benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Bayer
      • 7.5.4.1. Company overview
      • 7.5.4.2. Financial performance
      • 7.5.4.3. Product Type benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. GE HealthCare
      • 7.5.5.1. Company overview
      • 7.5.5.2. Financial performance
      • 7.5.5.3. Product Type benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Fresenius Kabi USA
      • 7.5.6.1. Company overview
      • 7.5.6.2. Financial performance
      • 7.5.6.3. Product Type benchmarking
      • 7.5.6.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 U.S. Peripheral Vascular Angiography Contrast Media Market, by Product, 2018 - 2030 (USD Million)
  • Table 4 U.S. Peripheral Vascular Angiography Contrast Media Market, by Modality, 2018 - 2030 (USD Million)
  • Table 5 U.S. Peripheral Vascular Angiography Contrast Media Market, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Participant's Overview
  • Table 7 Financial Performance
  • Table 8 Product Benchmarking
  • Table 9 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 U.S. Peripheral Vascular Angiography Contrast Media Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Product Marketplace: Key Takeaways
  • Fig. 14 U.S. Peripheral Vascular Angiography Contrast Media Market, for CT/X-ray, 2018 - 2030 (USD Million)
  • Fig. 15 U.S. Peripheral Vascular Angiography Contrast Media Market, for Magnetic Resonance Imaging, 2018 - 2030 (USD Million)
  • Fig. 16 U.S. Peripheral Vascular Angiography Contrast Media Market, for Ultrasound, 2018 - 2030 (USD Million)
  • Fig. 17 Modality Marketplace: Key Takeaways
  • Fig. 18 U.S. Peripheral Vascular Angiography Contrast Media Market, for Iodinated Contrast Media, 2018 - 2030 (USD Million)
  • Fig. 19 U.S. Peripheral Vascular Angiography Contrast Media Market, for Gadolinium-based Contrast Media, 2018 - 2030 (USD Million)
  • Fig. 20 U.S. Peripheral Vascular Angiography Contrast Media Market, for Microbubble, 2018 - 2030 (USD Million)
  • Fig. 21 End Use Marketplace: Key Takeaways
  • Fig. 22 U.S. Peripheral Vascular Angiography Contrast Media Market, for Hospitals, 2018 - 2030 (USD Million)
  • Fig. 23 U.S. Peripheral Vascular Angiography Contrast Media Market, for Diagnostic Imaging Centers, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. Peripheral Vascular Angiography Contrast Media Market, for Research Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. Peripheral Vascular Angiography Contrast Media Market, for Others, 2018 - 2030 (USD Million)